Gene Review:
Wdr5 - WD repeat domain 5
Mus musculus
Synonyms:
2410008O07Rik, AA408785, AA960360, BMP2-induced 3-kb gene protein, Big, ...
- Chronic Helicobacter pylori infections induce gastric mutations in mice. Touati, E., Michel, V., Thiberge, J.M., Wuscher, N., Huerre, M., Labigne, A. Gastroenterology (2003)
- Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea. Allay, E., Veigl, M., Gerson, S.L. Oncogene (1999)
- The mutagenic potential of duodenoesophageal reflux. Theisen, J., Peters, J.H., Fein, M., Hughes, M., Hagen, J.A., Demeester, S.R., Demeester, T.R., Laird, P.W. Ann. Surg. (2005)
- Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Hayward, J.J., Shane, B.S., Tindall, K.R., Cunningham, M.L. Carcinogenesis (1995)
- Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype. Hill, K.A., Buettner, V.L., Heidt, A., Chen, L.L., Li, W., Gonzalez, K.D., Wang, J.C., Scaringe, W.A., Sommer, S.S. Carcinogenesis (2006)
- Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Kuzmin, A., Madjid, N., Terenius, L., Ogren, S.O., Bakalkin, G. Neuropsychopharmacology (2006)
- Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Yoshida, Y., Tanaka, S., Umemori, H., Minowa, O., Usui, M., Ikematsu, N., Hosoda, E., Imamura, T., Kuno, J., Yamashita, T., Miyazono, K., Noda, M., Noda, T., Yamamoto, T. Cell (2000)
- The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. Morinobu, M., Nakamoto, T., Hino, K., Tsuji, K., Shen, Z.J., Nakashima, K., Nifuji, A., Yamamoto, H., Hirai, H., Noda, M. J. Exp. Med. (2005)
- Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. Zhao, M., Harris, S.E., Horn, D., Geng, Z., Nishimura, R., Mundy, G.R., Chen, D. J. Cell Biol. (2002)
- Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. Chen, D., Ji, X., Harris, M.A., Feng, J.Q., Karsenty, G., Celeste, A.J., Rosen, V., Mundy, G.R., Harris, S.E. J. Cell Biol. (1998)
- Effects of O (6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice. Sui, H., Suzuki, M., Yamada, M., Hara, T., Kawakami, K., Shibuya, T., Nohmi, T., Sofuni, T. Environ. Mol. Mutagen. (1999)
- Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice. Lefevre, P.A., Tinwell, H., Galloway, S.M., Hill, R., Mackay, J.M., Elcombe, C.R., Foster, J., Randall, V., Callander, R.D., Ashby, J. Human & experimental toxicology. (1994)
- Weak yet distinct mutagenicity of acrylamide in mammalian cells. Besaratinia, A., Pfeifer, G.P. J. Natl. Cancer Inst. (2003)
- Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. Gori, F., Friedman, L.G., Demay, M.B. Dev. Biol. (2006)
- Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6. Ogasawara, T., Kawaguchi, H., Jinno, S., Hoshi, K., Itaka, K., Takato, T., Nakamura, K., Okayama, H. Mol. Cell. Biol. (2004)
- Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. Liu, P.K., Hsu, C.Y., Dizdaroglu, M., Floyd, R.A., Kow, Y.W., Karakaya, A., Rabow, L.E., Cui, J.K. J. Neurosci. (1996)
- Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. Lemonnier, J., Ghayor, C., Guicheux, J., Caverzasio, J. J. Biol. Chem. (2004)
- Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. Shen, Z.J., Nakamoto, T., Tsuji, K., Nifuji, A., Miyazono, K., Komori, T., Hirai, H., Noda, M. J. Biol. Chem. (2002)
- Cloning and characterization of a novel WD-40 repeat protein that dramatically accelerates osteoblastic differentiation. Gori, F., Divieti, P., Demay, M.B. J. Biol. Chem. (2001)
- Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation. Besaratinia, A., Pfeifer, G.P. Cancer Res. (2003)
- Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Walker, V.E., Gorelick, N.J., Andrews, J.L., Craft, T.R., deBoer, J.G., Glickman, B.W., Skopek, T.R. Cancer Res. (1996)
- Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. Zhang, D., Mehler, M.F., Song, Q., Kessler, J.A. J. Neurosci. (1998)
- Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Kousteni, S., Almeida, M., Han, L., Bellido, T., Jilka, R.L., Manolagas, S.C. Mol. Cell. Biol. (2007)
- Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer. Besaratinia, A., Bates, S.E., Pfeifer, G.P. Cancer Res. (2002)
- Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. Chikazu, D., Li, X., Kawaguchi, H., Sakuma, Y., Voznesensky, O.S., Adams, D.J., Xu, M., Hoshio, K., Katavic, V., Herschman, H.R., Raisz, L.G., Pilbeam, C.C. J. Bone Miner. Res. (2002)
- Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. Guicheux, J., Lemonnier, J., Ghayor, C., Suzuki, A., Palmer, G., Caverzasio, J. J. Bone Miner. Res. (2003)
- Oxazepam is mutagenic in vivo in Big Blue transgenic mice. Shane, B.S., deBoer, J.G., Glickman, B.W., Cunningham, M.L. Carcinogenesis (1999)
- TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements. Hullinger, T.G., Pan, Q., Viswanathan, H.L., Somerman, M.J. Exp. Cell Res. (2001)
- Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. Nakashima, A., Katagiri, T., Tamura, M. J. Biol. Chem. (2005)
- Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Hata, K., Nishimura, R., Ikeda, F., Yamashita, K., Matsubara, T., Nokubi, T., Yoneda, T. Mol. Biol. Cell (2003)
- Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. Ghosh-Choudhury, N., Abboud, S.L., Nishimura, R., Celeste, A., Mahimainathan, L., Choudhury, G.G. J. Biol. Chem. (2002)
- Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells. Figueroa, J.D., Hayman, M.J. Exp. Cell Res. (2004)
- BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. Lee, M.H., Kim, Y.J., Kim, H.J., Park, H.D., Kang, A.R., Kyung, H.M., Sung, J.H., Wozney, J.M., Kim, H.J., Ryoo, H.M. J. Biol. Chem. (2003)
- Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. Nobta, M., Tsukazaki, T., Shibata, Y., Xin, C., Moriishi, T., Sakano, S., Shindo, H., Yamaguchi, A. J. Biol. Chem. (2005)
- Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Lou, J., Tu, Y., Li, S., Manske, P.R. Biochem. Biophys. Res. Commun. (2000)
- Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes. Park, G.T., Morasso, M.I. Nucleic Acids Res. (2002)
- BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K., Taga, T. J. Biol. Chem. (2000)
- Bone morphogenetic protein 2 stimulates articular cartilage proteoglycan synthesis in vivo but does not counteract interleukin-1alpha effects on proteoglycan synthesis and content. Glansbeek, H.L., van Beuningen, H.M., Vitters, E.L., Morris, E.A., van der Kraan, P.M., van den Berg, W.B. Arthritis Rheum. (1997)
- Identification of novel regulators associated with early-phase osteoblast differentiation. de Jong, D.S., Vaes, B.L., Dechering, K.J., Feijen, A., Hendriks, J.M., Wehrens, R., Mummery, C.L., van Zoelen, E.J., Olijve, W., Steegenga, W.T. J. Bone Miner. Res. (2004)
- LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice. Shane, B.S., de Boer, J., Watson, D.E., Haseman, J.K., Glickman, B.W., Tindall, K.R. Carcinogenesis (2000)